AVE — Avecho Biotechnology Cashflow Statement
0.000.00%
Last trade - 00:00- AU$12.68m
- AU$11.38m
- AU$1.13m
- 49
- 15
- 43
- 30
Annual cashflow statement for Avecho Biotechnology, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.78 | 0.516 | 1.04 | 0.759 | 1.13 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.42 | -3.1 | -1.67 | -3.18 | -3.97 |
| Capital Expenditures | -0.005 | -0.203 | -0.053 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.001 | — | — | — | -0.016 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.004 | -0.203 | -0.053 | 0 | -0.016 |
| Financing Cash Flow Items | — | -0.294 | 0 | -0.717 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.083 | 4.69 | -0.078 | 7.22 | 0.855 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.34 | 1.39 | -1.8 | 4.04 | -3.13 |